HILS Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: Tharimmune Inc.

Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl

2 months ago - By: Tharimmune Inc.

Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl

2 months ago - By: The Motley Fool - Mentions: CGTX IPDN MENS EQ

These Were the 5 Top-Performing Stocks in the Nasdaq Composite in August 2025

2 years ago - By: Benzinga - Mentions: PHAR ICU AGRX CFRX ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

2 years ago - By: Benzinga - Mentions: NBY NVOS SYBX CRNX ...

12 Health Care Stocks Moving In Monday's Intraday Session

2 years ago - By: Hillstream BioPharma, Inc.

Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic Pruritis

2 years ago - By: InvestorPlace - Mentions: CRNX VS JG CRKN ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

2 years ago - By: Hillstream BioPharma, Inc.

Hillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13

2 years ago - By: Hillstream BioPharma, Inc.

Hillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023

2 years ago - By: Hillstream BioPharma, Inc.

Hillstream Advances Next-Gen Multispecific Antibodies for Solid Tumors with Lead HER2/HER3 Program, HSB-3215

2 years ago - By: Hillstream BioPharma, Inc.

Hillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors via Bispecific and ADC Antibodies and Biologics

2 years ago - By: Hillstream BioPharma, Inc.

Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian Cancers

2 years ago - By: Hillstream BioPharma, Inc.

Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly Anderson

3 years ago - By: Hillstream BioPharma, Inc.

Hillstream BioPharma Announces Closing of Public Offering of Common Stock

3 years ago - By: Hillstream BioPharma, Inc.

Hillstream BioPharma to Present at Upcoming May 2023 Investor and Industry Conferences

3 years ago - By: InvestorPlace - Mentions: STZ NDRA AGBA

Why Is Constellation Brands (STZ) Stock Down Today?

3 years ago - By: InvestorPlace - Mentions: NDRA AGBA TOP

Why Is ENDRA Life Sciences (NDRA) Stock Down 16% Today?

3 years ago - By: InvestorPlace - Mentions: AGBA TOP

Why Is Hillstream BioPharma (HILS) Stock Down 57% Today?

3 years ago - By: InvestorPlace - Mentions: TOP AGBA MEGL DXF ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

3 years ago - By: Hillstream BioPharma, Inc.

Hillstream BioPharma Announces Pricing of Public Offering

3 years ago - By: Seeking Alpha

Hillstream BioPharma proposes stock and warrants offering, shares fall 20% (NASDAQ:HILS)

3 years ago - By: Hillstream BioPharma, Inc.

HILLSTREAM BIOPHARMA INC (HILS) Stock News

HILS Latest News, Press Relases and Analysis

Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl

Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl

These Were the 5 Top-Performing Stocks in the Nasdaq Composite in August 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Monday's Intraday Session

Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic Pruritis

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Hillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13

Hillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023

Hillstream Advances Next-Gen Multispecific Antibodies for Solid Tumors with Lead HER2/HER3 Program, HSB-3215

Hillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors via Bispecific and ADC Antibodies and Biologics

Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian Cancers

Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly Anderson

Hillstream BioPharma Announces Closing of Public Offering of Common Stock

Hillstream BioPharma to Present at Upcoming May 2023 Investor and Industry Conferences

Why Is Constellation Brands (STZ) Stock Down Today?

Why Is ENDRA Life Sciences (NDRA) Stock Down 16% Today?

Why Is Hillstream BioPharma (HILS) Stock Down 57% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Hillstream BioPharma Announces Pricing of Public Offering

Hillstream BioPharma proposes stock and warrants offering, shares fall 20% (NASDAQ:HILS)

Hillstream BioPharma Announces Proposed Public Offering